Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Elkum, Naser ^a   Dermime, Said ^a   Ajarim, Dahish ^a   Al Zahrani, Ali ^a   Alsayed, Adher ^a   Tulbah, Asma ^a   Al Malik, Osama ^a   Alshabanah, Mohamed ^a   Ezzat, Adnan ^a   Al Tweigeri, Taher ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADOLESCENT; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; RISK FACTOR; SAUDI ARABIA; TREATMENT OUTCOME; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; AGE; AXILLA; BREAST TUMOR; COMPARATIVE STUDY; LYMPH NODE; MASTECTOMY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL; TUMOR RECURRENCE; UNITED STATES;

ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS, HORMONAL; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA; SURVIVAL ANALYSIS; TAMOXIFEN; TREATMENT OUTCOME; UNITED STATES;

EID: 38949112797     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-222     Document Type: Article

References (36)

1. Tarone RE Breast cancer trends among young women in the United States Epidemiology (Cambridge, Mass) 2006, 17(5):588-590 16804474
2. Registry NC Cancer Incidence Report Saudi Arabia 2002 Riyadh 2007
3. Zabicki K Colbert JA Dominguez FJ Gadd MA Hughes KS Jones JL Specht MC Michaelson JS Smith BL Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: Increasing size and stage disparity compared with older women over time Ann Surg Oncol 2006, 13(8):1072-1077 10.1245/ ASO.2006.03.055 16865599
4. Bollet MA Sigal-Zafrani B Mazeau V Savignoni A de la Rochefordiere A Vincent-Salomon A Salmon R Campana F Kirova YM Dendale R Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first Radiother Oncol 2007, 82(3):272-280 10.1016/j.radonc.2007.01.001 17287037
5. Aryandono T Harijadi Soeripto Breast cancer in young women: Prognostic factors and clinicopathological features Asian Pac J Cancer Prev 2006, 7(3):451-454 17059343
6. Jayasinghe UW Taylor R Boyages J Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ journal of surgery 2005, 75(9):762-767 10.1111/j.1445-2197.2005.03515.x 16173989
7. Foo CS Su D Chong CK Chng HC Tay KH Low SC Tan SM Breast cancer in young Asian women: Study on survival ANZ journal of surgery 2005, 75(7):566-572 10.1111/j.1445-2197.2005.03431.x 15972049
8. Han W Kim SW Park IA Kang D Kim SW Youn YK Oh SK Choe KJ Noh DY Young age: An independent risk factor for disease-free survival in women with operable breast cancer BMC cancer 2004, 4:82 545947 15546499 10.1186/ 1471-2407-4-82
9. Colleoni M Rotmensz N Robertson C Orlando L Viale G Renne G Luini A Veronesi P Intra M Orecchia R Very young women (<35 years) with operable breast cancer: Features of disease at presentation Ann Oncol 2002, 13(2):273-279 10.1093/annonc/mdf039 11886005
10. Khanfir A Frikha M Kallel F Meziou M Trabelsi K Boudawara T Mnif J Daoud J [Breast cancer in young women in the south of Tunisia] Cancer Radiother 2006, 10(8):565-571 17140835
11. Henderson IC Patek AJ Are breast cancers in young women qualitatively distinct? Lancet 1997, 349(9064):1488-1489 10.1016/S0140-6736(97)22021-0 9167452
12. Anderson BO Senie RT Vetto JT Wong GY McCormick B Borgen PI Improved survival in young women with breast cancer Ann Surg Oncol 1995, 2(5):407-415 10.1007/BF02306373 7496835
13. Muscolino G Villani C Bedini AV Luini A Salvadori B Young age is not an ominous prognostic factor in breast cancer patients Tumori 1987, 73(3):233-235 3603718
14. Rapiti E Fioretta G Verkooijen HM Vlastos G Schafer P Sappino AP Kurtz J Neyroud-Caspar I Bouchardy C Survival of young and older breast cancer patients in Geneva from 1990 to 2001 Eur J Cancer 2005, 41(10):1446-1452 10.1016/j.ejca.2005.02.029 15919199
15. Chia KS Du WB Sankaranarayanan R Sankila R Wang H Lee J Seow A Lee HP Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis International journal of cancer 2004, 108(5):761-765 10.1002/ijc.11632
16. Nixon AJ Neuberg D Hayes DF Gelman R Connolly JL Schnitt S Abner A Recht A Vicini F Harris JR Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer J Clin Oncol 1994, 12(5):888-894 8164038
17. Agrup M Stal O Olsen K Wingren S C-erbB-2 overexpression and survival in early onset breast cancer Breast cancer research and treatment 2000, 63(1):23-29 10.1023/A:1006498721508
18. Albain KS Allred DC Clark GM Breast cancer outcome and predictors of outcome: Are there age differentials? Journal of the National Cancer Institute 1994, 16 35-42 7999467
19. Walker RA Lees E Webb MB Dearing SJ Breast carcinomas occurring in young women (< 35 years) are different Br J Cancer 1996, 74(11):1796-1800 8956795
20. Adami HO Malker B Rutqvist LE Persson I Ries L Temporal trends in breast cancer survival in Sweden: Significant improvement in 20 years J Natl Cancer Inst 1986, 76(4):653-659 3457203
21. Winchester DP Osteen RT Menck HR The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age Cancer 1996, 78(8):1838-1843 10.1002/ (SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-Y 8859200
22. American-Joint-Committee-on-Cancer AJCC Cancer Staging Manual Philadelphia, PA: Lippincott-Raven 5 1997:171-180
23. Kaplan E Meier P Non parametric estimation for incomplete observation J Am Stat Assoc 1958, 53:550-556 10.2307/2281868
24. Cox D Regression models and life tables J R Stat Soc 1972, 34:187-220
25. Gajdos C Tartter PI Bleiweiss IJ Bodian C Brower ST Stage 0 to stage III breast cancer in young women J Am Coll Surg 2000, 190(5):523-529 10.1016/ S1072-7515(00)00257-X 10801018
26. de la Rochefordiere A Asselain B Campana F Scholl SM Fenton J Vilcoq JR Durand JC Pouillart P Magdelenat H Fourquet A Age as prognostic factor in premenopausal breast carcinoma Lancet 1993, 341(8852):1039-1043 10.1016/0140-6736(93)92407-K 8096955
27. Fowble BL Schultz DJ Overmoyer B Solin LJ Fox K Jardines L Orel S Glick JH The influence of young age on outcome in early stage breast cancer International journal of radiation oncology, biology, physics 1994, 30(1):23-33 8083119
28. Xiong Q Valero V Kau V Kau SW Taylor S Smith TL Buzdar AU Hortobagyi GN Theriault RL Female patients with breast carcinoma age 30 years and younger have a poor prognosis: The M.D. Anderson Cancer Center experience Cancer 2001, 92(10):2523-2528 10.1002/ 1097-0142(20011115)92:10<2523::AID-CNCR1603>3.0.CO;2-6 11745185
29. Robson M Gilewski T Haas B Levin D Borgen P Rajan P Hirschaut Y Pressman P Rosen PP Lesser ML BRCA-associated breast cancer in young women J Clin Oncol 1998, 16(5):642-1649 9586873
30. Peto J Collins N Barfoot R Seal S Warren W Rahman N Easton DF Evans C Deacon J Stratton MR Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 1999, 91(11):943-949 10.1093/jnci/91.11.943 10359546
31. Choi DH Lee MH Bale AE Carter D Haffty BG Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients J Clin Oncol 2004, 22(9):1638-1645 10.1200/JCO.2004.04.179 15117986
32. Sng JH Chang J Feroze F Rahman N Tan W Lim S Lehnert M van der Pool S Wong J The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives Br J Cancer 2000, 82(3):538-542 10.1054/bjoc.1999.0960 10682662
33. El-Harith el HA Abdel-Hadi MS Steinmann D Dork T BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia Saudi Med J 2002, 23(6):700-704 12070551
34. Eerola H Heikkila P Tamminen A Aittomaki K Blomqvist C Nevanlinna H Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families Breast Cancer Res 2005, 7(4):R465-469 1175056 15987451 10.1186/bcr1025
35. Levy-Lahad E Friedman E Cancer risks among BRCA1 and BRCA2 mutation carriers Br J Cancer 2007, 96(1):11-15 10.1038/sj.bjc.6603535 17213823
36. van de Vijver MJ He YD van't Veer LJ Dai H Hart AA Voskuil DW Schreiber GJ Peterse JL Roberts C Marton MJ A gene-expression signature as a predictor of survival in breast cancer The New England journal of medicine 2002, 347(25):1999-2009 10.1056/NEJMoa021967 12490681